Healthcare - Biotechnology - NASDAQ - US
$ 0.023
0 %
$ 532 K
Market Cap
-0.16
P/E
BALANCE SHEET
2.6 M
ASSETS
20.8 M
LIABILITIES
-18.2 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Peak Bio, Inc.
| Current Assets | 2.37 M |
| Cash & Short-Term Investments | 382 K |
| Receivables | 75.2 K |
| Other Current Assets | 1.92 M |
| Non-Current Assets | 222 K |
| Long-Term Investments | 16.5 |
| PP&E | 153 K |
| Other Non-Current Assets | 69.2 K |
| Current Liabilities | 20.5 M |
| Accounts Payable | 5.86 M |
| Short-Term Debt | 10.7 M |
| Other Current Liabilities | 3.94 M |
| Non-Current Liabilities | 231 K |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 231 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 0.4 | 0.7 | 0.2 | 7.67 K | 11 K |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 |
| Receivables | 75.2 K | 0.2 | 0 | 0 | 0 |
| Inventory | 0 | (2 575 898.7) | 0 | 0 | 0 |
| Other Current Assets | 1.9 | 2.3 | 0.3 | 178 | 28.2 |
| Total Current Assets | 2.4 | 3.2 | 0.5 | 7.85 K | 11.1 K |
| PP&E | 0.2 | 4.1 | 0.4 | 245 | 141 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 16.5 | 26.7 | 43.1 | 0 | 0 |
| Other Long Term Assets | 69.2 K | 0.2 | 0.2 | 2.22 K | 645 |
| Other Assets | 0 | 0 | 0 | 0.651 | 0.0571 |
| Total Assets | 2.6 | 7.5 | 1.1 | 10.3 K | 11.9 K |
| LIABILITIES | |||||
| Accounts Payable | 5.9 | 3.6 | 0.3 | 145 | 494 |
| Short Term Debt | 10.7 | 2.1 | 1.5 | 0 | 0 |
| Other Current Liabilities | 3.9 | 5.1 | 0.9 | 21.6 | 61.7 |
| Total Current Liabilities | 20.5 | 10.8 | 2.8 | 167 | 555 |
| Long Term Debt | 0 | 3.5 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 35 K | 0 | 0 |
| Other Liabilities | 0.2 | 1.3 | 0.2 | 0 | 0 |
| Total Liabilities | 20.8 | 15.6 | 3.0 | 167 | 555 |
| EQUITY | |||||
| Common Stock | 2.31 K | 1.98 K | 1.72 K | 13.9 K | 4.09 K |
| Retained Earnings | (38.2) | (25.3) | (8.5) | 4.77 K | 2.27 K |
| Other Accumulative Comprehensive Income/Loss | 93.6 K | 29.5 K | 88.4 K | 967 | 9.47 K |
| Total Equity | (18.2) | (8.1) | (1.9) | 10.1 K | 11.3 K |
| Total Liabilities and Equity | 2.6 | 7.5 | 1.1 | 10.3 K | 11.9 K |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 29.5 | 17.7 | 17.2 | 6.7 | 3.6 |